Breast Cancer
Studies from University of Paris describe new findings in breast cancer
Published in Women's Health Weekly, December 17th, 2009
In this recent article published in the Journal of Clinical Oncology, scientists in Villejuif, France conducted a study "To investigate whether the relation between estrogen-progestagen menopausal hormone therapy (EP-MHT) and breast cancer risk varies according to the delay between menopause onset and treatment initiation. Between 1992 and 2005, 1,726 invasive breast cancers were identified among 53,310 postmenopausal women from the French E3N cohort (mean duration of follow-up, 8.1 years)."
"Hazard ratios (HRs) and CIs were estimated using Cox models, with MHT never users as the reference. Among recent users of EP-MHT, the risk of breast cancer varied according...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Journal of the National Cancer Institute
News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response - Research Institute of Molecular Pathology
A RANK insider resolving the enigma of the fever chart - Yale University
Hormone ghrelin can boost resistance to Parkinson's disease - Angiogenesis
Studies conducted at Federal University of Minas Gerais on angiogenesis recently published - Angiogenesis
Study data from S.H. Yang and co-authors update knowledge of angiogenesis - Autism
Treatments for Asthma and Pre-Term Labor May Increase Risk of Autism-Spectrum Disorders in the Developing Fetus - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
